Press Release: System Bioscience : System Biosciences Announces New Non-Exclusive License of ExoQuick® Technology to QIAGEN

System Biosciences (SBI), a leading provider of exosome research tools and services, announced today that QIAGEN, a leading global provider of Sample to Insights solutions for molecular diagnostics and life sciences, has signed a non-exclusive, worldwide license for SBI's patented ExoQuick� technology for research use. QIAGEN intends to use the ExoQuick technology in precipitation-based miRCURY" products complementing its leading portfolio of spin column-based exoEasy and exoRNeasy product lines.